Amgen (AMGN) Net Margin (2009 - 2026)

Amgen has reported Net Margin for 18 years, with the latest figure at 23.62% in Q2 2026.

• On a quarterly basis, Net Margin rose 802.0% year-over-year to 23.62% in Q2 2026; TTM through Jun 2026 was 22.95%, a 399.0% increase from a year earlier, with the FY2025 full-year figure at 20.98%, up 875.0% from the prior year.
• Net Margin was 23.62% for Q2 2026 at Amgen, up from 21.11% in the prior quarter.
• The five-year high for Net Margin was 352.07% in Q4 2022, with the low at 1.52% in Q1 2024.
• Average Net Margin over 5 years is 39.16%, with a median of 21.17% recorded in 2026.
• The sharpest annual moves came in 2022 and 2023: Net Margin jumped 32433 bps in 2022, then tumbled 34271 bps in 2023.
• Over 5 years, Net Margin stood at 352.07% in 2022, then plunged by 97 bps to 9.36% in 2023, then declined by 26 bps to 6.9% in 2024, then surged by 96 bps to 13.51% in 2025, then jumped by 75 bps to 23.62% in 2026.
• The last three Net Margin figures came in at 23.62% (Q2 2026), 21.11% (Q1 2026), and 13.51% (Q4 2025), per Business Quant data.